Protect Affordable IVC!

New information has come to light that poses a threat for continued consumer access to intravenous vitamin C (IVC), a potent, safe, and natural treatment for viral and bacterial infections and some cancers. It is a blatant example of our crony medical system. If we don’t stand up and send a strong message to Congress and the FDA, affordable IVC will be a thing of the past.

This is particularly important given the recent COVID-19 pandemic. China is exploring the efficacy of using IVC to treat coronavirus infections. Vitamin C has been demonstrated to have anti-viral properties; it has also demonstrated efficacy against sepsis and respiratory infections. In addition to making sure there isn't a shortage of IVC, government health authorities should aggressively research the viability of using IVC in the current pandemic.

Write to Congress and the FDA, asking them not to enforce market exclusivity for the FDA-approved IVC product and to research IVC for treating the coronavirus.

Recipients

Your Senators
Your Representative
Food and Drug Administration

Contact

*Required fields

* Title:

* First Name:

* Last Name:

* Your Email:

* Address 1:

Address 2:

* City:

* State / Province:

* ZIP / Postal Code:

Country:

* Phone Number:

Yes, I would like to receive periodic updates and communications from Alliance for Natural Health USA.

Remember me. What's this?

Message

Please protect affordable intravenous vitamin C

Dear [Decision Maker],

* Personalize your message

Intravenous vitamin C (IVC) is a potent natural treatment for a variety of illnesses, including cancer and infections. Where it was once widely and cheaply available, now one company has a monopoly on IVC and it is less accessible. Please do not enforce market exclusivity for this substance. Instead, allow other manufacturers to produce it.

In 2017, McGuff Pharmaceuticals received FDA approval for an IVC product for the treatment of scurvy, and thus market exclusivity. The FDA notified other manufacturers of IVC that they must stop producing it, giving them a one-year grace period that has now expired. McGuff has subsequently raised the price of IVC.

McGuff received Orphan Drug Approval for its IVC product. Taking advantage of the Orphan Drug Program is a familiar move. We've seen it done with Epidiolex, the CBD drug. Epidiolex won orphan drug designation for the treatment of a rare form of childhood epilepsy. The drug maker now has a government-granted monopoly on the CBD market, knowing full well doctors will prescribe Epidiolex (which will cost $32,500 a year) off-label to patients for many ailments. We will likely see a similar scenario play out with McGuff's IVC. It has won FDA approval as an orphan drug for scurvy, but since it is now the only IVC product on the market it will be prescribed off-label for a variety of illnesses.

Taxpayers are subsidizing the creation of drug monopolies that are driving up the cost of healthcare and hindering our access to healthy products.

The FDA-created monopoly on IVC will hurt patients. This is a medicine that is ubiquitous in integrative medicine practices as a key ingredient in Myers' Cocktails, chelation, and cancer IVs. IVC is not normally covered by insurance, so patients need to pay out of pocket. Intravenous administration of nutrients is crucial, as it allows patients to achieve serum concentrations of nutrients that are not obtainable through oral administration. For example, vitamin C's antiviral effect has been demonstrated to occur at 10-15 mG/dL, a level that can only be achieved intravenously.

Cancer patients require multiple vials in a single session and can have multiple sessions per week. IVC is also a potent antiviral, so these patients will also have to pay a premium or simply go without it.

Like CBD, the case of IVC is a prime example of the crony medical system--a cheap, safe, and effective natural medicine widely available to consumers is once again turned into an expensive monopoly drug. Please do not enforce market exclusivity for McGuff's IVC product, and pursue research on vitamin C's ability to fight the coronavirus.

Sincerely,
[Your Name]
[Your Address]
[City, State ZIP]
[Your Email]